早期运用活血化瘀法治疗中小量高血压性脑出血38例疗效观察

目的:观察早期运用活血化瘀法治疗中小量高血压性脑出血的疗效。方法:将经CT检查确诊的急性期高血压性脑出血68例随机分为2组。治疗组38例,在西医常规综合治疗基础上加用香丹注射液静滴;对照组30例,采用西医常规综合治疗。2组均以28天为1疗程。观察2组疗效、治疗前后神经功能缺损积分及血肿吸收情况。结果:显效率、总有效率治疗组分别为65.79％、94.74％,对照组分别为40.00％、86.67％。2组显效率比较,差异有显著性意义(P<0.05);但总有效率比较,差异无显著性意义(P>0.05)。治疗后治疗组神经功能缺损积分与对照组比较,差异有显著性意义(P<0.05)。血肿完全吸收率治疗组与对照组比较,差异有显著性意义(P<0.05)。结论:早期运用活血化瘀法治疗中小量高血压性脑出血具有良好的作用,能促进颅内血肿吸收。

A Clinical Observation on Application of Blood-Circulation Activating and Blood- Stasis Removing Therapy for Early Stage of Moderate and Small Volume Hypertensive Cerebral Hemorrhage

Objective: To observe the curative effect of blood - circulation activating and blood - stasis removing therapy (BBT) for early stage of hypertensive cerebral hemorrhage (HCH). Methods: 68 cases of acute stage of HCH confirmed by CT were allocated to 2 groups randomly. The treatment group (38 cases) was treated by routine comprehensive treatment added with IV drips of Xiagdan in- jection and the control group (30 cases) by routine western medicine. 28 days constituted a course of treatment. The therapeu- tic effects, scoring of neural dysfunction and the absorption of hematoma were observed before and after treatment. Results: The markedly effective rate and total effective rate were 65. 79% and 94. 74% respectively in treatment group, and 40. 00% and 86. 67% in control group, the markedly effective rate being signifi- cantly different between 2 group (P < 0.05) while the total effec- tive rate being no siginficantly different (P > 0.05). The scoring of neural dysfunction after treatment was significantly different be- tween 2 groups (P < 0.05), while the absorptive rate of hematoma was also significantly different (P < 0.05). Conclusion: Application of BBT in the early stage of HCH possesses good curative effect, which can promote the absorption of intracranial hematoma.